Millennium Management increased its stake in Alvotech stock, which trades on Nasdaq, with details published on MarketBeat.
3 reports, 1 independent
Updated Thu 00:00
No new developments lately
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Millennium Management increased its stake in Alvotech stock, which trades on Nasdaq, with details published on MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alvotech
biotechnology company
Nothing else this week.
-
Millennium Management
alternative investment management firm
Related events
- Millennium Management increased its stake in Amprius Technologies, Inc. stock, and the CEO filed the required transaction disclosure with the SEC.
- Millennium Management increased its stake in nCino Inc. by 16.6% and filed the transaction with the SEC.
- Millennium Management increased its stake in AbbVie and purchased shares of SpaceX stock on September 12, 2026.
- Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.
- The stock of Safety Insurance Group, Inc., an insurance provider, is listed on the Nasdaq exchange, and Millennium Management has reduced its stake.